Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

BACKGROUND/AIMS: Breast cancer metastasis suppressor 1 (BRMS1) blocks metastasis in melanoma xenografts; however, its usefulness as a biomarker in human melanomas has not been widely studied. The goal was to measure BRMS1 expression in benign nevi, primary and metastatic melanomas and evaluate its i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341185/
https://ncbi.nlm.nih.gov/pubmed/22356677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-73
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak